Status | Study |
Recruiting |
Study Name: Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas Condition: Neurofibromatosis Type 2 Vestibular Schwannomas Date: 2014-04-29 Interventions: Drug: Axitinib Other Name: Inlyta |
Recruiting |
Study Name: Cyberknife Radiosurgery for Patients With Neurinomas Condition: Sporadic Acoustic Neuromas Useful Hearing Date: 2014-01-31 Interventions: Radiation: Radiosurgery Other Name: Cyberknife (Accuray) |
Recruiting |
Study Name: Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study Condition: Vestibular Schwannoma Date: 2013-09-05 Interventions: Radiation: Initial Gamma knife radiosurgery |
Recruiting |
Study Name: Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas Condition: Neurofibromatosis Type 2 Vestibular Schwannomas Date: 2013-06-11 Interventions: Drug: RAD001 Other Name: Everolimus |
Active, not recruiting |
Study Name: Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Condition: Neurofibromatosis Type 2 Progressive Vestibular Schwannomas Date: 2013-01-07 Interventions: Drug: Bevacizumab Treatment will be administered on an out |
Recruiting |
Study Name: Vestibular Schwannoma and Psychological Factors Condition: Vestibular Schwannoma Date: 2012-09-28 |
Recruiting |
Study Name: Stereotactic Radiation in Vestibular Schwannoma Condition: Vestibular Schwannoma Date: 2011-10-02 Interventions: Radiation: stereotactic radiotherapy |
Recruiting |
Study Name: Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma Condition: Neurofibromatosis Type 2 Neuroma, Acoustic Date: 2011-04-21 Interventions: Drug: RAD001, everolimus Adults: 10 mg p.o. daily dose, age 16 - 17: 3.0 mg/m2 p.o. daily |
Terminated |
Study Name: A Study of Nilotinib in Growing Vestibular Schwannomas Condition: Growing Vestibular Schwannomas Date: 2010-09-13 Interventions: Drug: Nilotinib |
Recruiting |
Study Name: Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma Condition: Vestibular Schwannoma Acoustic Neuroma Date: 2010-09-09 Interventions: Radiation: Fractionated proton radiation Given daily for approximately 5.5 weeks |